Skip to main content
Top
Published in: Rheumatology International 11/2006

01-09-2006 | Original Article

Celecoxib inhibits nitric oxide production in chondrocytes of ligament-damaged osteoarthritic rat joints

Authors: Kenta Matsuda, Shigeru Nakamura, Takashi Matsushita

Published in: Rheumatology International | Issue 11/2006

Login to get access

Abstract

The purpose of this study was to demonstrate the direct effects of celecoxib, one of the selective cyclo-oxygenase (COX)-2 inhibitors, on nitric oxide (NO) and prostaglandinE2 (PGE2) synthesis in cultured osteoarthritic chondrocyte comparing with those of indomethacin. Articular chondrocytes were isolated from rat osteoarthritic knee joint with damaged anterior cruciate ligament and also from the sham knee joint. Chondrocytes were preincubated with or without IL-1 alpha, and were exposed to celecoxib, indomethacin (non-selective COX inhibitor), or nothing. The amounts of NO and PGE2 in culture supernatants of chondrocytes were measured by EIA or the Griess reaction. In a series of experiments preincubated with or without IL-1 alpha and exposed to nothing, PGE2 and NO levels were significantly higher in osteoarthritic chondrocytes than in sham chondrocytes. Celecoxib and indomethacin inhibited the increase of PGE2 in osteoarthritic chondrocytes. Celecoxib inhibited and indomethacin did not inhibit the increase of NO levels in osteoarthritic chondrocytes.
Literature
1.
go back to reference Smith WL, Garavito RM, Dewitt DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271:33157–33160PubMedCrossRef Smith WL, Garavito RM, Dewitt DL (1996) Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 271:33157–33160PubMedCrossRef
2.
go back to reference Mastbergen SC (2002) Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage. Rheumatology 41:801–808PubMedCrossRef Mastbergen SC (2002) Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage. Rheumatology 41:801–808PubMedCrossRef
3.
go back to reference Mitchell JA, Akarasereenont P, Thiemermann C, Flower CRJ, Vane JR (1993) Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90:11693–11697PubMedCrossRef Mitchell JA, Akarasereenont P, Thiemermann C, Flower CRJ, Vane JR (1993) Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90:11693–11697PubMedCrossRef
4.
go back to reference Brandt KD (1987) Nonsteroidal anti-inflammatory drugs and articular cartilage. J Rheumatol 14:132–133PubMed Brandt KD (1987) Nonsteroidal anti-inflammatory drugs and articular cartilage. J Rheumatol 14:132–133PubMed
5.
go back to reference Pettipher ER, Henderson B, Edwards JC, HA Higgs (1989) Effects of indomethacin on swelling, lymphocyte influx and cartilage proteoglycan depletion in experimental arthritis. Ann Rheum Dis 48:623–627PubMedCrossRef Pettipher ER, Henderson B, Edwards JC, HA Higgs (1989) Effects of indomethacin on swelling, lymphocyte influx and cartilage proteoglycan depletion in experimental arthritis. Ann Rheum Dis 48:623–627PubMedCrossRef
6.
go back to reference EI Hajjaji H, Marcelis A, Devogelaer JP, Manicourt DH (2003) Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage. J Rheumatol 30:2444–2451PubMed EI Hajjaji H, Marcelis A, Devogelaer JP, Manicourt DH (2003) Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage. J Rheumatol 30:2444–2451PubMed
7.
go back to reference Gilroy DW, Tomlinson A, Greenslade K, Speed MP, Willoughby DA (1998) The effects of cyclooxygenase-2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the rat. Inflammation 22:509–519PubMedCrossRef Gilroy DW, Tomlinson A, Greenslade K, Speed MP, Willoughby DA (1998) The effects of cyclooxygenase-2 inhibitors on cartilage erosion and bone loss in a model of Mycobacterium tuberculosis-induced monoarticular arthritis in the rat. Inflammation 22:509–519PubMedCrossRef
8.
go back to reference Hulth A, Lindberg L, Telhag H (1970) Experimental osteoarthritis in rabbits. Act Orthop Scandinav 41:522–530CrossRef Hulth A, Lindberg L, Telhag H (1970) Experimental osteoarthritis in rabbits. Act Orthop Scandinav 41:522–530CrossRef
9.
go back to reference Kawiak J, Moskalewski S, Darzynkiewicz Z (1965) Isolation of chondrocytes from calf cartilage. Exp Cell Res 39:59–63PubMedCrossRef Kawiak J, Moskalewski S, Darzynkiewicz Z (1965) Isolation of chondrocytes from calf cartilage. Exp Cell Res 39:59–63PubMedCrossRef
10.
go back to reference Yasui N, Ochi T, Ono Y (1986) Influence of anti-inflammatory analgesics on metabolism of cartilage. Jpn Pharmacol Ther 14:439–442 Yasui N, Ochi T, Ono Y (1986) Influence of anti-inflammatory analgesics on metabolism of cartilage. Jpn Pharmacol Ther 14:439–442
11.
go back to reference Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and 15N-nitrate in biological fluids. Anal Biochem 126:131–138PubMedCrossRef Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and 15N-nitrate in biological fluids. Anal Biochem 126:131–138PubMedCrossRef
12.
go back to reference Fukuda K, Ohtani K, Dan H, Tanaka S (1995) Interleukin-1 inhibits keratan sulfate production by rabbit chondrocytes: possible role of prostaglandin E2. Inflamm Res 44:434–437PubMedCrossRef Fukuda K, Ohtani K, Dan H, Tanaka S (1995) Interleukin-1 inhibits keratan sulfate production by rabbit chondrocytes: possible role of prostaglandin E2. Inflamm Res 44:434–437PubMedCrossRef
13.
go back to reference Abramson SB (1999) The role of COX-2 produced by cartilage in arthritis. Osteoarthr Cartil 7:380–381PubMedCrossRef Abramson SB (1999) The role of COX-2 produced by cartilage in arthritis. Osteoarthr Cartil 7:380–381PubMedCrossRef
14.
go back to reference Di Battista JA, Dore S, Martel-Pelletier J, Pelletier JP (1996) Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: identification of an effector autocrine loop involving insulin-like growth factor 1. Mol Cell Endocrinol 123:27–35PubMedCrossRef Di Battista JA, Dore S, Martel-Pelletier J, Pelletier JP (1996) Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: identification of an effector autocrine loop involving insulin-like growth factor 1. Mol Cell Endocrinol 123:27–35PubMedCrossRef
15.
go back to reference Lowe GN, Fu YH, McDougall S, Polendo R, Williams A, Benya PD, Hahn TJ (1996) Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers. Endocrinology 137:2208–2216PubMedCrossRef Lowe GN, Fu YH, McDougall S, Polendo R, Williams A, Benya PD, Hahn TJ (1996) Effects of prostaglandins on deoxyribonucleic acid and aggrecan synthesis in the RCJ 3.1C5.18 chondrocyte cell line: role of second messengers. Endocrinology 137:2208–2216PubMedCrossRef
16.
go back to reference Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C (1994) Nitric oxide mediates suppression of cartilage proteogly can synthesis by interleukin-1. Biochem Biophys Res Commun 200:142–148PubMedCrossRef Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C (1994) Nitric oxide mediates suppression of cartilage proteogly can synthesis by interleukin-1. Biochem Biophys Res Commun 200:142–148PubMedCrossRef
17.
go back to reference Cao M, Westerhausen-Larson A, Niyibizi C, Kavalkovich K, Georgescu HI, Rizzo CF, Hebda PA, Stefanovic-Racic M, Evans CH (1997) Nitric oxide inhibits the synthesis of type-2 collagen without altering Col2A1 mRNA abundance: prolylhydroxylase as a possible target. Biochem J 324:305–310PubMed Cao M, Westerhausen-Larson A, Niyibizi C, Kavalkovich K, Georgescu HI, Rizzo CF, Hebda PA, Stefanovic-Racic M, Evans CH (1997) Nitric oxide inhibits the synthesis of type-2 collagen without altering Col2A1 mRNA abundance: prolylhydroxylase as a possible target. Biochem J 324:305–310PubMed
18.
go back to reference Tamura T, Nakanishi T, Kimura Y, Hattori T, Sasaki K, Norimatsu H, Takahashi K, Takigawa M (1996) Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology 137:3729–3737PubMedCrossRef Tamura T, Nakanishi T, Kimura Y, Hattori T, Sasaki K, Norimatsu H, Takahashi K, Takigawa M (1996) Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology 137:3729–3737PubMedCrossRef
19.
go back to reference Notoya K, Jovanovic D, Reboul P, Johanne M, Mineau F, Pelletier JP (2000) The Induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 165:3402–3410PubMed Notoya K, Jovanovic D, Reboul P, Johanne M, Mineau F, Pelletier JP (2000) The Induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 165:3402–3410PubMed
20.
go back to reference Fermor B, Weinberg JB, Pisetsky DS, Misukonis MA, Fink C, Guilak F (2002) Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway. Osteoarthr Cartil 10:792–798PubMedCrossRef Fermor B, Weinberg JB, Pisetsky DS, Misukonis MA, Fink C, Guilak F (2002) Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway. Osteoarthr Cartil 10:792–798PubMedCrossRef
21.
go back to reference Pelletier JP, Fernandes JC, Jovanovic DV, Reboul P, Martel-Pelletier J (2001) Chondrocyte death in experimental osteoarthritis is mediated by MEK1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase. J Rheumatol 28:2509–2519PubMed Pelletier JP, Fernandes JC, Jovanovic DV, Reboul P, Martel-Pelletier J (2001) Chondrocyte death in experimental osteoarthritis is mediated by MEK1/2 and p38 pathways: role of cyclooxygenase-2 and inducible nitric oxide synthase. J Rheumatol 28:2509–2519PubMed
22.
go back to reference Nedelec E, Abid A, Cipolletta C, Presle N, Terlain B, Netter P, Jouzeau J (2001) Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism. Biochem Pharmacol 61:965–978PubMedCrossRef Nedelec E, Abid A, Cipolletta C, Presle N, Terlain B, Netter P, Jouzeau J (2001) Stimulation of cyclooxygenase-2-activity by nitric oxide-derived species in rat chondrocyte: lack of contribution to loss of cartilage anabolism. Biochem Pharmacol 61:965–978PubMedCrossRef
23.
go back to reference Amin AR, Dave M, Attur M, Abramson SB (2000) COX-2, NO, and cartilage damage and repair. Curr Rheumatol Rep 2:447–453PubMedCrossRef Amin AR, Dave M, Attur M, Abramson SB (2000) COX-2, NO, and cartilage damage and repair. Curr Rheumatol Rep 2:447–453PubMedCrossRef
24.
go back to reference Abramson SB, Attur MG, Amin AR, Clancy R (2001) Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3:535–541PubMedCrossRef Abramson SB, Attur MG, Amin AR, Clancy R (2001) Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3:535–541PubMedCrossRef
Metadata
Title
Celecoxib inhibits nitric oxide production in chondrocytes of ligament-damaged osteoarthritic rat joints
Authors
Kenta Matsuda
Shigeru Nakamura
Takashi Matsushita
Publication date
01-09-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0107-6

Other articles of this Issue 11/2006

Rheumatology International 11/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.